Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2207130
Max Phase: Preclinical
Molecular Formula: C52H73N11O15S2
Molecular Weight: 1156.35
Molecule Type: Protein
Associated Items:
ID: ALA2207130
Max Phase: Preclinical
Molecular Formula: C52H73N11O15S2
Molecular Weight: 1156.35
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)OCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C52H73N11O15S2/c1-5-28(4)43-50(75)56-33(17-18-40(54)65)45(70)58-36(23-41(55)66)47(72)61-38(26-80-79-25-32(53)44(69)57-35(48(73)62-43)21-30-13-15-31(64)16-14-30)51(76)63-19-9-12-39(63)49(74)59-34(20-27(2)3)46(71)60-37(52(77)78-24-42(67)68)22-29-10-7-6-8-11-29/h6-8,10-11,13-16,27-28,32-39,43,64H,5,9,12,17-26,53H2,1-4H3,(H2,54,65)(H2,55,66)(H,56,75)(H,57,69)(H,58,70)(H,59,74)(H,60,71)(H,61,72)(H,62,73)(H,67,68)/t28-,32-,33-,34-,35-,36-,37-,38-,39-,43-/m0/s1
Standard InChI Key: QRVJKPSXBPQXRE-ZDGWERHOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1156.35 | Molecular Weight (Monoisotopic): 1155.4729 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Morris KM, Cao F, Onagi H, Altamore TM, Gamble AB, Easton CJ.. (2012) Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency., 22 (23): [PMID:23084901] [10.1016/j.bmcl.2012.10.004] |
Source(1):